Last reviewed · How we verify
Restylane
At a glance
| Generic name | Restylane |
|---|---|
| Sponsor | Medicis Aesthetics, Inc. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine (NA)
- Randomized Masked Trial of Injectable Cross-Linked Hyaluronic Acid for Moderate-to-Severe Nasolabial Folds (NA)
- Hyaluronic Acid Filler Migration (NA)
- Post-Menopause Skin Rejuvenation Study (PHASE4)
- The Correction of Midface Volume Deficiency and/or Midface Contour Deficiency (NA)
- Safety and Effectiveness of Restylane® Kysse for Lip Augmentation in Chinese Subjects (NA)
- Comparing Pain, Safety and Effectiveness of Restylane Skinboosters Vital Lido and Vital Without Lido in Dorsal Hand (NA)
- Pan-Facial Layering of Hyaluronic Acid Filler (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Restylane CI brief — competitive landscape report
- Restylane updates RSS · CI watch RSS
- Medicis Aesthetics, Inc. portfolio CI